Journal of Advanced Biotechnology and Experimental Therapeutics (Apr 2023)

Biofilm formation by the interaction of fungi (Candida tropicalis) with various bacteria

  • Dwi Wahyuning Asih,
  • Agung Dwi Wahyu Widodo,
  • Rebekah Juniati Setiabudi,
  • Sulistiawati,
  • Wiwiek Tyasningsih,
  • Manik Retno Wahyunitisari

DOI
https://doi.org/10.5455/jabet.2023.d108
Journal volume & issue
Vol. 6, no. 1
pp. 84 – 93

Abstract

Read online

Acinetobacter baumannii) ABSTRACT: Background: Biofilms are composed of more than one species or often called polymicrobial biofilms, so research is needed on the formation of polymicrobial biofilms, especially between fungi and bacteria. This study aimed to analyze the total biomass and metabolic activity of biofilms formed from the interaction of fungi (Candida tropicalis) with bacteria (Staphylococcus aureus, MRSA, Pseudomonas aeruginosa, and Acinetobacter baumannii); Methods: Bacterial and fungal cultures were suspended in Tryptic Soy Broth (TSB) medium, then biofilm was cultivated in two 96-well microplates, then the microplates were incubated at 37 degrees Celsius for 48 hours. Detection of the biofilm will be carried out using the Crystal Violet assay and reduction of the tetrazolium salt (3-(4,5-dimethylthiazol-2-yl)-2,5-Diphenyltetrazolium Bromide), or MTT assay to obtain the Optical Density (OD) value by using ELISA reader; Results: The results of this study obtained significant data from both parameters, the highest average value was found in the C. tropicalis treatment group (2,412 ± 0.825 on the biomass test results; 1,525 ± 0.473 on the metabolic activity test results), while the lowest was seen in the S. aureus treatment group (0.512 ± 0.224 in the biomass test results; 0.978 ± 0.349 in the metabolic activity test results); and Conclusions: In the total biomass parameter, it was obtained that the biofilm biomass could be formed strongly in each treatment, while the results of the metabolic activity showed that each treatment was able to carry out cell proliferation. [ J Adv Biotechnol Exp Ther 2023; 6(1.000): 84-93]

Keywords